← Back
$URGN All transactions

UroGen Pharma Ltd.

▼ SELL

$ Value

$52K

Shares

2,654

Price

$20

Filed

Feb 11

Insider

Name

Smith Jason Drew

Title

General Counsel

CIK

0001821479

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

52,934

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. | The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. | The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. | The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. | 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

Filing Info

Accession No.

0001437749-26-003778

Form Type

4

Issuer CIK

0001668243

Smith Jason Drew's History

Date Ticker Type Value
2026-02-03 URGN $52K
2026-02-03 URGN $32K
2026-02-03 URGN $63K
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN A $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$95K 2026-02-03